Oluwadolapo D. Lawal

A deeper look at pain variability and its relationship with the placebo response: results from a randomized, double-blind, placebo-controlled clinical trial of naproxen in osteoarthritis of the knee

Roi Treister, Liat Honigman, Oluwadolapo D. Lawal et al. · Pain · 2019 · 63 citations

Accurate pain reporting training diminishes the placebo response: Results from a randomised, double-blind, crossover trial

Roi Treister, Oluwadolapo D. Lawal, Jonathan D. Shecter et al. · PLoS ONE · 2018 · 50 citations · Full text

Pain Therapy, Pain Disorders, Placebo Response +18

Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study

Oluwadolapo D. Lawal, Herbert D. Aronow, Fisayomi Shobayo et al. · Circulation · 2023 · 47 citations · Full text

Association Between Prenatal Opioid Exposure and Neurodevelopmental Outcomes in Early Childhood: A Retrospective Cohort Study

Xuerong Wen, Oluwadolapo D. Lawal, Nicholas Belviso et al. · Drug Safety · 2021 · 21 citations · Full text

Retrospective Cohort Study, Early Life Exposure, Neurodevelopmental Outcomes +11

The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database

Oluwadolapo D. Lawal, Maitreyee Mohanty, Harrison Elder et al. · Expert Opinion on Drug Safety · 2018 · 15 citations · Full text